Electromed, Inc. (ELMD) Research

Electromed, Inc. is engaged in the creation, production, and sale of respiratory therapy devices. Their focus is on delivering airway clearance through High Frequency Chest Wall Oscillation (HFCWO) technology, aiding pulmonary care for individuals of all ages across the United States and globally. The company's key offering is the SmartVest airway clearance system. This includes the SmartVest SQL System, an innovative solution comprising an inflatable therapy garment, a customizable air pulse generator, and a distinctive single-hose design for air delivery. They also provide SmartVest Connect, a wireless platform enabling personalized HFCWO therapy management for patients with diminished lung function. For acute care settings, Electromed supplies single-use SmartVest and SmartVest Wrap products to healthcare providers. Electromed's primary market is home healthcare, catering to patients diagnosed with conditions such as bronchiectasis, cystic fibrosis, and neuromuscular disease. The company distributes its products via medical professionals, healthcare facilities, and directly to consumers. Established in 1992, Electromed, Inc. is based in New Prague, Minnesota.

Open Electromed, Inc. (ELMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.